As of 2026-04-13, the Relative Valuation of Vir Biotechnology Inc (VIR) is (41.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Vir Biotechnology Inc based on Relative Valuation is -540.8%.
The range of the Relative Valuation is (34.60) - (51.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 18.6x | 12.1x |
| Forward P/E multiples | 12.6x - 22.8x | 18.4x |
| Fair Price | (34.60) - (51.04) | (41.87) |
| Upside | -464.2% - -637.3% | -540.8% |
| Date | P/E |
| 2026-04-10 | -3.47 |
| 2026-04-09 | -3.59 |
| 2026-04-08 | -3.47 |
| 2026-04-07 | -3.35 |
| 2026-04-06 | -3.30 |
| 2026-04-02 | -3.30 |
| 2026-04-01 | -3.29 |
| 2026-03-31 | -3.27 |
| 2026-03-30 | -3.09 |
| 2026-03-27 | -3.06 |
| 2026-03-26 | -3.27 |
| 2026-03-25 | -3.28 |
| 2026-03-24 | -3.13 |
| 2026-03-23 | -3.22 |
| 2026-03-20 | -3.32 |
| 2026-03-19 | -3.42 |
| 2026-03-18 | -3.40 |
| 2026-03-17 | -3.46 |
| 2026-03-16 | -3.53 |
| 2026-03-13 | -3.38 |
| 2026-03-12 | -3.46 |
| 2026-03-11 | -3.58 |
| 2026-03-10 | -3.60 |
| 2026-03-09 | -3.57 |
| 2026-03-06 | -3.48 |
| 2026-03-05 | -3.32 |
| 2026-03-04 | -3.49 |
| 2026-03-03 | -3.25 |
| 2026-03-02 | -3.41 |
| 2026-02-27 | -3.32 |
| 2026-02-26 | -3.40 |
| 2026-02-25 | -3.65 |
| 2026-02-24 | -3.46 |
| 2026-02-23 | -2.71 |
| 2026-02-20 | -2.76 |
| 2026-02-19 | -2.85 |
| 2026-02-18 | -2.86 |
| 2026-02-17 | -2.74 |
| 2026-02-13 | -2.72 |
| 2026-02-12 | -2.81 |
| 2026-02-11 | -2.71 |
| 2026-02-10 | -2.74 |
| 2026-02-09 | -2.66 |
| 2026-02-06 | -2.62 |
| 2026-02-05 | -2.52 |
| 2026-02-04 | -2.74 |
| 2026-02-03 | -2.80 |
| 2026-02-02 | -2.81 |
| 2026-01-30 | -2.71 |
| 2026-01-29 | -2.84 |